Loading…

Effect of l-arginine on energy metabolism, skeletal muscle and brown adipose tissue in South Asian and Europid prediabetic men: a randomised double-blinded crossover study

Aims/hypothesis Individuals of South Asian origin are at increased risk of developing type 2 diabetes mellitus and associated comorbidities compared with Europids. Disturbances in energy metabolism may contribute to this increased risk. Skeletal muscle and possibly also brown adipose tissue (BAT) ar...

Full description

Saved in:
Bibliographic Details
Published in:Diabetologia 2019-01, Vol.62 (1), p.112-122
Main Authors: Boon, Mariëtte R., Hanssen, Mark J. W., Brans, Boudewijn, Hülsman, Cindy J. M., Hoeks, Joris, Nahon, Kimberly J., Bakker, Charlotte, van Klinken, Jan B., Havekes, Bas, Schaart, Gert, Jazet, Ingrid M., Rensen, Patrick C. N., van Marken Lichtenbelt, Wouter D.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c470t-857923622ae8d8d8f532cf7e62fb75ec6ee6054ddff868eb74c55302b6a10f863
cites cdi_FETCH-LOGICAL-c470t-857923622ae8d8d8f532cf7e62fb75ec6ee6054ddff868eb74c55302b6a10f863
container_end_page 122
container_issue 1
container_start_page 112
container_title Diabetologia
container_volume 62
creator Boon, Mariëtte R.
Hanssen, Mark J. W.
Brans, Boudewijn
Hülsman, Cindy J. M.
Hoeks, Joris
Nahon, Kimberly J.
Bakker, Charlotte
van Klinken, Jan B.
Havekes, Bas
Schaart, Gert
Jazet, Ingrid M.
Rensen, Patrick C. N.
van Marken Lichtenbelt, Wouter D.
description Aims/hypothesis Individuals of South Asian origin are at increased risk of developing type 2 diabetes mellitus and associated comorbidities compared with Europids. Disturbances in energy metabolism may contribute to this increased risk. Skeletal muscle and possibly also brown adipose tissue (BAT) are involved in human energy metabolism and nitric oxide (NO) is suggested to play a pivotal role in regulating mitochondrial biogenesis in both tissues. We aimed to investigate the effects of 6 weeks of supplementation with l -arginine, a precursor of NO, on energy metabolism by BAT and skeletal muscle, as well as glucose metabolism in South Asian men compared with men of European descent. Methods We included ten Dutch South Asian men (age 46.5 ± 2.8 years, BMI 30.1 ± 1.1 kg/m 2 ) and ten Dutch men of European descent, that were similar with respect to age and BMI, with prediabetes (fasting plasma glucose level 5.6–6.9 mmol/l or plasma glucose levels 2 h after an OGTT 7.8–11.1 mmol/l). Participants took either l -arginine (9 g/day) or placebo orally for 6 weeks in a randomised double-blind crossover study. Participants were eligible to participate in the study when they were aged between 40 and 55 years, had a BMI between 25 and 35 kg/m 2 and did not have type 2 diabetes. Furthermore, ethnicity was defined as having four grandparents of South Asian or white European origin, respectively. Blinding of treatment was done by the pharmacy (Hankintatukku) and an independent researcher from Leiden University Medical Center randomly assigned treatments by providing a coded list. All people involved in the study as well as participants were blinded to group assignment. After each intervention, glucose tolerance was determined by OGTT and basal metabolic rate (BMR) was determined by indirect calorimetry; BAT activity was assessed by cold-induced [ 18 F]fluorodeoxyglucose ([ 18 F]FDG) positron emission tomography–computed tomography scanning. In addition, a fasting skeletal muscle biopsy was taken and analysed ex vivo for respiratory capacity using a multisubstrate protocol. The primary study endpoint was the effect of l -arginine on BAT volume and activity. Results l -Arginine did not affect BMR, [ 18 F]FDG uptake by BAT or skeletal muscle respiration in either ethnicity. During OGTT, l -arginine lowered plasma glucose concentrations (AUC 0–2 h  − 9%, p  
doi_str_mv 10.1007/s00125-018-4752-6
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6290676</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2127090492</sourcerecordid><originalsourceid>FETCH-LOGICAL-c470t-857923622ae8d8d8f532cf7e62fb75ec6ee6054ddff868eb74c55302b6a10f863</originalsourceid><addsrcrecordid>eNp1UsuOFCEUJUbj9LR-gBtD4sbFlAJVBdUuTCaT9pFM4kJN3BEKbvUwUlBCMaa_yZ-U6h7HR2JYkMs5HO7hHoSeUPKCEiJeJkIoaytCu6oRLav4PbSiTc0q0rDuPlotcEU7_uUEnaZ0TQip24Y_RCc1qYUQlK3Qj-0wgJ5xGLCrVNxZbz3g4DF4iLs9HmFWfXA2jWc4fQVXSofHnLQDrLzBfQzfPVbGTiEBnm1KGbD1-GPI8xU-T1b5A2-bY5iswVMEY1UPs9VF27_CCseCh9EmMNiE3Duoeme9KaWOIaVwAxGnOZv9I_RgUC7B49t9jT6_2X66eFddfnj7_uL8stKNIHPVtWLDas6Ygs6UNbQ104MAzoZetKA5ACdtY8wwdLyDXjS6bWvCeq4oKUf1Gr0-6k65H8Fo8HNUTk7RjiruZVBW_o14eyV34UZytiFcLALPbwVi-JYhzbLY0-Cc8hBykowywTkRZQxr9Owf6nXI0Rd7BxbZkKaYWSN6ZB1-JMJw1wwlcomCPEZBlijIJQpyaeLpny7ubvyafSGwIyEVyO8g_n76_6o_AXFDwrY</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2127090492</pqid></control><display><type>article</type><title>Effect of l-arginine on energy metabolism, skeletal muscle and brown adipose tissue in South Asian and Europid prediabetic men: a randomised double-blinded crossover study</title><source>Springer Link</source><creator>Boon, Mariëtte R. ; Hanssen, Mark J. W. ; Brans, Boudewijn ; Hülsman, Cindy J. M. ; Hoeks, Joris ; Nahon, Kimberly J. ; Bakker, Charlotte ; van Klinken, Jan B. ; Havekes, Bas ; Schaart, Gert ; Jazet, Ingrid M. ; Rensen, Patrick C. N. ; van Marken Lichtenbelt, Wouter D.</creator><creatorcontrib>Boon, Mariëtte R. ; Hanssen, Mark J. W. ; Brans, Boudewijn ; Hülsman, Cindy J. M. ; Hoeks, Joris ; Nahon, Kimberly J. ; Bakker, Charlotte ; van Klinken, Jan B. ; Havekes, Bas ; Schaart, Gert ; Jazet, Ingrid M. ; Rensen, Patrick C. N. ; van Marken Lichtenbelt, Wouter D.</creatorcontrib><description>Aims/hypothesis Individuals of South Asian origin are at increased risk of developing type 2 diabetes mellitus and associated comorbidities compared with Europids. Disturbances in energy metabolism may contribute to this increased risk. Skeletal muscle and possibly also brown adipose tissue (BAT) are involved in human energy metabolism and nitric oxide (NO) is suggested to play a pivotal role in regulating mitochondrial biogenesis in both tissues. We aimed to investigate the effects of 6 weeks of supplementation with l -arginine, a precursor of NO, on energy metabolism by BAT and skeletal muscle, as well as glucose metabolism in South Asian men compared with men of European descent. Methods We included ten Dutch South Asian men (age 46.5 ± 2.8 years, BMI 30.1 ± 1.1 kg/m 2 ) and ten Dutch men of European descent, that were similar with respect to age and BMI, with prediabetes (fasting plasma glucose level 5.6–6.9 mmol/l or plasma glucose levels 2 h after an OGTT 7.8–11.1 mmol/l). Participants took either l -arginine (9 g/day) or placebo orally for 6 weeks in a randomised double-blind crossover study. Participants were eligible to participate in the study when they were aged between 40 and 55 years, had a BMI between 25 and 35 kg/m 2 and did not have type 2 diabetes. Furthermore, ethnicity was defined as having four grandparents of South Asian or white European origin, respectively. Blinding of treatment was done by the pharmacy (Hankintatukku) and an independent researcher from Leiden University Medical Center randomly assigned treatments by providing a coded list. All people involved in the study as well as participants were blinded to group assignment. After each intervention, glucose tolerance was determined by OGTT and basal metabolic rate (BMR) was determined by indirect calorimetry; BAT activity was assessed by cold-induced [ 18 F]fluorodeoxyglucose ([ 18 F]FDG) positron emission tomography–computed tomography scanning. In addition, a fasting skeletal muscle biopsy was taken and analysed ex vivo for respiratory capacity using a multisubstrate protocol. The primary study endpoint was the effect of l -arginine on BAT volume and activity. Results l -Arginine did not affect BMR, [ 18 F]FDG uptake by BAT or skeletal muscle respiration in either ethnicity. During OGTT, l -arginine lowered plasma glucose concentrations (AUC 0–2 h  − 9%, p  &lt; 0.01), insulin excursion (AUC 0–2 h  − 26%, p  &lt; 0.05) and peak insulin concentrations (−26%, p  &lt; 0.05) in Europid but not South Asian men. This coincided with enhanced cold-induced glucose oxidation (+44%, p  &lt; 0.05) in Europids only. Of note, in skeletal muscle biopsies several respiration states were consistently lower in South Asian men compared with Europid men. Conclusions/interpretation l -Arginine supplementation does not affect BMR, [ 18 F]FDG uptake by BAT, or skeletal muscle mitochondrial respiration in Europid and South Asian overweight and prediabetic men. However, l -arginine improves glucose tolerance in Europids but not in South Asians. Furthermore, South Asian men have lower skeletal muscle oxidative capacity than men of European descent. Funding This study was funded by the EU FP7 project DIABAT, the Netherlands Organization for Scientific Research, the Dutch Diabetes Research Foundation and the Dutch Heart Foundation. Trial registration: ClinicalTrials.gov NCT02291458.</description><identifier>ISSN: 0012-186X</identifier><identifier>EISSN: 1432-0428</identifier><identifier>DOI: 10.1007/s00125-018-4752-6</identifier><identifier>PMID: 30377712</identifier><language>eng</language><publisher>Berlin/Heidelberg: Springer Berlin Heidelberg</publisher><subject>Adipose tissue ; Adipose tissue (brown) ; Adipose Tissue, Brown - drug effects ; Adipose Tissue, Brown - metabolism ; Adult ; Arginine ; Arginine - therapeutic use ; Biopsy ; Blood Glucose ; Body Mass Index ; Body weight ; Calorimetry ; Computed tomography ; Cross-Over Studies ; Diabetes ; Diabetes mellitus ; Diabetes mellitus (non-insulin dependent) ; Diabetes Mellitus, Type 2 - drug therapy ; Diabetes Mellitus, Type 2 - metabolism ; Double-Blind Method ; Electron transport ; Energy metabolism ; Energy Metabolism - drug effects ; Ethnicity ; Fasting ; Glucose ; Glucose metabolism ; Glucose tolerance ; Human Physiology ; Humans ; Insulin ; Internal Medicine ; Laboratory testing ; Male ; Medicine ; Medicine &amp; Public Health ; Mens health ; Metabolic Diseases ; Metabolic rate ; Metabolism ; Middle Aged ; Minority &amp; ethnic groups ; Mitochondria ; Muscle, Skeletal - drug effects ; Muscle, Skeletal - metabolism ; Musculoskeletal system ; Nitric oxide ; Overweight ; Oxidation ; Positron emission tomography ; Prediabetic State ; Respiration ; Skeletal muscle ; Supplements ; Thermogenesis - drug effects</subject><ispartof>Diabetologia, 2019-01, Vol.62 (1), p.112-122</ispartof><rights>The Author(s) 2018</rights><rights>Diabetologia is a copyright of Springer, (2018). All Rights Reserved. © 2018. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c470t-857923622ae8d8d8f532cf7e62fb75ec6ee6054ddff868eb74c55302b6a10f863</citedby><cites>FETCH-LOGICAL-c470t-857923622ae8d8d8f532cf7e62fb75ec6ee6054ddff868eb74c55302b6a10f863</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,315,786,790,891,27957,27958</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/30377712$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Boon, Mariëtte R.</creatorcontrib><creatorcontrib>Hanssen, Mark J. W.</creatorcontrib><creatorcontrib>Brans, Boudewijn</creatorcontrib><creatorcontrib>Hülsman, Cindy J. M.</creatorcontrib><creatorcontrib>Hoeks, Joris</creatorcontrib><creatorcontrib>Nahon, Kimberly J.</creatorcontrib><creatorcontrib>Bakker, Charlotte</creatorcontrib><creatorcontrib>van Klinken, Jan B.</creatorcontrib><creatorcontrib>Havekes, Bas</creatorcontrib><creatorcontrib>Schaart, Gert</creatorcontrib><creatorcontrib>Jazet, Ingrid M.</creatorcontrib><creatorcontrib>Rensen, Patrick C. N.</creatorcontrib><creatorcontrib>van Marken Lichtenbelt, Wouter D.</creatorcontrib><title>Effect of l-arginine on energy metabolism, skeletal muscle and brown adipose tissue in South Asian and Europid prediabetic men: a randomised double-blinded crossover study</title><title>Diabetologia</title><addtitle>Diabetologia</addtitle><addtitle>Diabetologia</addtitle><description>Aims/hypothesis Individuals of South Asian origin are at increased risk of developing type 2 diabetes mellitus and associated comorbidities compared with Europids. Disturbances in energy metabolism may contribute to this increased risk. Skeletal muscle and possibly also brown adipose tissue (BAT) are involved in human energy metabolism and nitric oxide (NO) is suggested to play a pivotal role in regulating mitochondrial biogenesis in both tissues. We aimed to investigate the effects of 6 weeks of supplementation with l -arginine, a precursor of NO, on energy metabolism by BAT and skeletal muscle, as well as glucose metabolism in South Asian men compared with men of European descent. Methods We included ten Dutch South Asian men (age 46.5 ± 2.8 years, BMI 30.1 ± 1.1 kg/m 2 ) and ten Dutch men of European descent, that were similar with respect to age and BMI, with prediabetes (fasting plasma glucose level 5.6–6.9 mmol/l or plasma glucose levels 2 h after an OGTT 7.8–11.1 mmol/l). Participants took either l -arginine (9 g/day) or placebo orally for 6 weeks in a randomised double-blind crossover study. Participants were eligible to participate in the study when they were aged between 40 and 55 years, had a BMI between 25 and 35 kg/m 2 and did not have type 2 diabetes. Furthermore, ethnicity was defined as having four grandparents of South Asian or white European origin, respectively. Blinding of treatment was done by the pharmacy (Hankintatukku) and an independent researcher from Leiden University Medical Center randomly assigned treatments by providing a coded list. All people involved in the study as well as participants were blinded to group assignment. After each intervention, glucose tolerance was determined by OGTT and basal metabolic rate (BMR) was determined by indirect calorimetry; BAT activity was assessed by cold-induced [ 18 F]fluorodeoxyglucose ([ 18 F]FDG) positron emission tomography–computed tomography scanning. In addition, a fasting skeletal muscle biopsy was taken and analysed ex vivo for respiratory capacity using a multisubstrate protocol. The primary study endpoint was the effect of l -arginine on BAT volume and activity. Results l -Arginine did not affect BMR, [ 18 F]FDG uptake by BAT or skeletal muscle respiration in either ethnicity. During OGTT, l -arginine lowered plasma glucose concentrations (AUC 0–2 h  − 9%, p  &lt; 0.01), insulin excursion (AUC 0–2 h  − 26%, p  &lt; 0.05) and peak insulin concentrations (−26%, p  &lt; 0.05) in Europid but not South Asian men. This coincided with enhanced cold-induced glucose oxidation (+44%, p  &lt; 0.05) in Europids only. Of note, in skeletal muscle biopsies several respiration states were consistently lower in South Asian men compared with Europid men. Conclusions/interpretation l -Arginine supplementation does not affect BMR, [ 18 F]FDG uptake by BAT, or skeletal muscle mitochondrial respiration in Europid and South Asian overweight and prediabetic men. However, l -arginine improves glucose tolerance in Europids but not in South Asians. Furthermore, South Asian men have lower skeletal muscle oxidative capacity than men of European descent. Funding This study was funded by the EU FP7 project DIABAT, the Netherlands Organization for Scientific Research, the Dutch Diabetes Research Foundation and the Dutch Heart Foundation. Trial registration: ClinicalTrials.gov NCT02291458.</description><subject>Adipose tissue</subject><subject>Adipose tissue (brown)</subject><subject>Adipose Tissue, Brown - drug effects</subject><subject>Adipose Tissue, Brown - metabolism</subject><subject>Adult</subject><subject>Arginine</subject><subject>Arginine - therapeutic use</subject><subject>Biopsy</subject><subject>Blood Glucose</subject><subject>Body Mass Index</subject><subject>Body weight</subject><subject>Calorimetry</subject><subject>Computed tomography</subject><subject>Cross-Over Studies</subject><subject>Diabetes</subject><subject>Diabetes mellitus</subject><subject>Diabetes mellitus (non-insulin dependent)</subject><subject>Diabetes Mellitus, Type 2 - drug therapy</subject><subject>Diabetes Mellitus, Type 2 - metabolism</subject><subject>Double-Blind Method</subject><subject>Electron transport</subject><subject>Energy metabolism</subject><subject>Energy Metabolism - drug effects</subject><subject>Ethnicity</subject><subject>Fasting</subject><subject>Glucose</subject><subject>Glucose metabolism</subject><subject>Glucose tolerance</subject><subject>Human Physiology</subject><subject>Humans</subject><subject>Insulin</subject><subject>Internal Medicine</subject><subject>Laboratory testing</subject><subject>Male</subject><subject>Medicine</subject><subject>Medicine &amp; Public Health</subject><subject>Mens health</subject><subject>Metabolic Diseases</subject><subject>Metabolic rate</subject><subject>Metabolism</subject><subject>Middle Aged</subject><subject>Minority &amp; ethnic groups</subject><subject>Mitochondria</subject><subject>Muscle, Skeletal - drug effects</subject><subject>Muscle, Skeletal - metabolism</subject><subject>Musculoskeletal system</subject><subject>Nitric oxide</subject><subject>Overweight</subject><subject>Oxidation</subject><subject>Positron emission tomography</subject><subject>Prediabetic State</subject><subject>Respiration</subject><subject>Skeletal muscle</subject><subject>Supplements</subject><subject>Thermogenesis - drug effects</subject><issn>0012-186X</issn><issn>1432-0428</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><recordid>eNp1UsuOFCEUJUbj9LR-gBtD4sbFlAJVBdUuTCaT9pFM4kJN3BEKbvUwUlBCMaa_yZ-U6h7HR2JYkMs5HO7hHoSeUPKCEiJeJkIoaytCu6oRLav4PbSiTc0q0rDuPlotcEU7_uUEnaZ0TQip24Y_RCc1qYUQlK3Qj-0wgJ5xGLCrVNxZbz3g4DF4iLs9HmFWfXA2jWc4fQVXSofHnLQDrLzBfQzfPVbGTiEBnm1KGbD1-GPI8xU-T1b5A2-bY5iswVMEY1UPs9VF27_CCseCh9EmMNiE3Duoeme9KaWOIaVwAxGnOZv9I_RgUC7B49t9jT6_2X66eFddfnj7_uL8stKNIHPVtWLDas6Ygs6UNbQ104MAzoZetKA5ACdtY8wwdLyDXjS6bWvCeq4oKUf1Gr0-6k65H8Fo8HNUTk7RjiruZVBW_o14eyV34UZytiFcLALPbwVi-JYhzbLY0-Cc8hBykowywTkRZQxr9Owf6nXI0Rd7BxbZkKaYWSN6ZB1-JMJw1wwlcomCPEZBlijIJQpyaeLpny7ubvyafSGwIyEVyO8g_n76_6o_AXFDwrY</recordid><startdate>20190101</startdate><enddate>20190101</enddate><creator>Boon, Mariëtte R.</creator><creator>Hanssen, Mark J. W.</creator><creator>Brans, Boudewijn</creator><creator>Hülsman, Cindy J. M.</creator><creator>Hoeks, Joris</creator><creator>Nahon, Kimberly J.</creator><creator>Bakker, Charlotte</creator><creator>van Klinken, Jan B.</creator><creator>Havekes, Bas</creator><creator>Schaart, Gert</creator><creator>Jazet, Ingrid M.</creator><creator>Rensen, Patrick C. N.</creator><creator>van Marken Lichtenbelt, Wouter D.</creator><general>Springer Berlin Heidelberg</general><general>Springer Nature B.V</general><scope>C6C</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7T5</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>H94</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20190101</creationdate><title>Effect of l-arginine on energy metabolism, skeletal muscle and brown adipose tissue in South Asian and Europid prediabetic men: a randomised double-blinded crossover study</title><author>Boon, Mariëtte R. ; Hanssen, Mark J. W. ; Brans, Boudewijn ; Hülsman, Cindy J. M. ; Hoeks, Joris ; Nahon, Kimberly J. ; Bakker, Charlotte ; van Klinken, Jan B. ; Havekes, Bas ; Schaart, Gert ; Jazet, Ingrid M. ; Rensen, Patrick C. N. ; van Marken Lichtenbelt, Wouter D.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c470t-857923622ae8d8d8f532cf7e62fb75ec6ee6054ddff868eb74c55302b6a10f863</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>Adipose tissue</topic><topic>Adipose tissue (brown)</topic><topic>Adipose Tissue, Brown - drug effects</topic><topic>Adipose Tissue, Brown - metabolism</topic><topic>Adult</topic><topic>Arginine</topic><topic>Arginine - therapeutic use</topic><topic>Biopsy</topic><topic>Blood Glucose</topic><topic>Body Mass Index</topic><topic>Body weight</topic><topic>Calorimetry</topic><topic>Computed tomography</topic><topic>Cross-Over Studies</topic><topic>Diabetes</topic><topic>Diabetes mellitus</topic><topic>Diabetes mellitus (non-insulin dependent)</topic><topic>Diabetes Mellitus, Type 2 - drug therapy</topic><topic>Diabetes Mellitus, Type 2 - metabolism</topic><topic>Double-Blind Method</topic><topic>Electron transport</topic><topic>Energy metabolism</topic><topic>Energy Metabolism - drug effects</topic><topic>Ethnicity</topic><topic>Fasting</topic><topic>Glucose</topic><topic>Glucose metabolism</topic><topic>Glucose tolerance</topic><topic>Human Physiology</topic><topic>Humans</topic><topic>Insulin</topic><topic>Internal Medicine</topic><topic>Laboratory testing</topic><topic>Male</topic><topic>Medicine</topic><topic>Medicine &amp; Public Health</topic><topic>Mens health</topic><topic>Metabolic Diseases</topic><topic>Metabolic rate</topic><topic>Metabolism</topic><topic>Middle Aged</topic><topic>Minority &amp; ethnic groups</topic><topic>Mitochondria</topic><topic>Muscle, Skeletal - drug effects</topic><topic>Muscle, Skeletal - metabolism</topic><topic>Musculoskeletal system</topic><topic>Nitric oxide</topic><topic>Overweight</topic><topic>Oxidation</topic><topic>Positron emission tomography</topic><topic>Prediabetic State</topic><topic>Respiration</topic><topic>Skeletal muscle</topic><topic>Supplements</topic><topic>Thermogenesis - drug effects</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Boon, Mariëtte R.</creatorcontrib><creatorcontrib>Hanssen, Mark J. W.</creatorcontrib><creatorcontrib>Brans, Boudewijn</creatorcontrib><creatorcontrib>Hülsman, Cindy J. M.</creatorcontrib><creatorcontrib>Hoeks, Joris</creatorcontrib><creatorcontrib>Nahon, Kimberly J.</creatorcontrib><creatorcontrib>Bakker, Charlotte</creatorcontrib><creatorcontrib>van Klinken, Jan B.</creatorcontrib><creatorcontrib>Havekes, Bas</creatorcontrib><creatorcontrib>Schaart, Gert</creatorcontrib><creatorcontrib>Jazet, Ingrid M.</creatorcontrib><creatorcontrib>Rensen, Patrick C. N.</creatorcontrib><creatorcontrib>van Marken Lichtenbelt, Wouter D.</creatorcontrib><collection>SpringerOpen</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Immunology Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Diabetologia</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Boon, Mariëtte R.</au><au>Hanssen, Mark J. W.</au><au>Brans, Boudewijn</au><au>Hülsman, Cindy J. M.</au><au>Hoeks, Joris</au><au>Nahon, Kimberly J.</au><au>Bakker, Charlotte</au><au>van Klinken, Jan B.</au><au>Havekes, Bas</au><au>Schaart, Gert</au><au>Jazet, Ingrid M.</au><au>Rensen, Patrick C. N.</au><au>van Marken Lichtenbelt, Wouter D.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Effect of l-arginine on energy metabolism, skeletal muscle and brown adipose tissue in South Asian and Europid prediabetic men: a randomised double-blinded crossover study</atitle><jtitle>Diabetologia</jtitle><stitle>Diabetologia</stitle><addtitle>Diabetologia</addtitle><date>2019-01-01</date><risdate>2019</risdate><volume>62</volume><issue>1</issue><spage>112</spage><epage>122</epage><pages>112-122</pages><issn>0012-186X</issn><eissn>1432-0428</eissn><notes>ObjectType-Article-2</notes><notes>SourceType-Scholarly Journals-1</notes><notes>ObjectType-News-1</notes><notes>ObjectType-Feature-3</notes><notes>content type line 23</notes><abstract>Aims/hypothesis Individuals of South Asian origin are at increased risk of developing type 2 diabetes mellitus and associated comorbidities compared with Europids. Disturbances in energy metabolism may contribute to this increased risk. Skeletal muscle and possibly also brown adipose tissue (BAT) are involved in human energy metabolism and nitric oxide (NO) is suggested to play a pivotal role in regulating mitochondrial biogenesis in both tissues. We aimed to investigate the effects of 6 weeks of supplementation with l -arginine, a precursor of NO, on energy metabolism by BAT and skeletal muscle, as well as glucose metabolism in South Asian men compared with men of European descent. Methods We included ten Dutch South Asian men (age 46.5 ± 2.8 years, BMI 30.1 ± 1.1 kg/m 2 ) and ten Dutch men of European descent, that were similar with respect to age and BMI, with prediabetes (fasting plasma glucose level 5.6–6.9 mmol/l or plasma glucose levels 2 h after an OGTT 7.8–11.1 mmol/l). Participants took either l -arginine (9 g/day) or placebo orally for 6 weeks in a randomised double-blind crossover study. Participants were eligible to participate in the study when they were aged between 40 and 55 years, had a BMI between 25 and 35 kg/m 2 and did not have type 2 diabetes. Furthermore, ethnicity was defined as having four grandparents of South Asian or white European origin, respectively. Blinding of treatment was done by the pharmacy (Hankintatukku) and an independent researcher from Leiden University Medical Center randomly assigned treatments by providing a coded list. All people involved in the study as well as participants were blinded to group assignment. After each intervention, glucose tolerance was determined by OGTT and basal metabolic rate (BMR) was determined by indirect calorimetry; BAT activity was assessed by cold-induced [ 18 F]fluorodeoxyglucose ([ 18 F]FDG) positron emission tomography–computed tomography scanning. In addition, a fasting skeletal muscle biopsy was taken and analysed ex vivo for respiratory capacity using a multisubstrate protocol. The primary study endpoint was the effect of l -arginine on BAT volume and activity. Results l -Arginine did not affect BMR, [ 18 F]FDG uptake by BAT or skeletal muscle respiration in either ethnicity. During OGTT, l -arginine lowered plasma glucose concentrations (AUC 0–2 h  − 9%, p  &lt; 0.01), insulin excursion (AUC 0–2 h  − 26%, p  &lt; 0.05) and peak insulin concentrations (−26%, p  &lt; 0.05) in Europid but not South Asian men. This coincided with enhanced cold-induced glucose oxidation (+44%, p  &lt; 0.05) in Europids only. Of note, in skeletal muscle biopsies several respiration states were consistently lower in South Asian men compared with Europid men. Conclusions/interpretation l -Arginine supplementation does not affect BMR, [ 18 F]FDG uptake by BAT, or skeletal muscle mitochondrial respiration in Europid and South Asian overweight and prediabetic men. However, l -arginine improves glucose tolerance in Europids but not in South Asians. Furthermore, South Asian men have lower skeletal muscle oxidative capacity than men of European descent. Funding This study was funded by the EU FP7 project DIABAT, the Netherlands Organization for Scientific Research, the Dutch Diabetes Research Foundation and the Dutch Heart Foundation. Trial registration: ClinicalTrials.gov NCT02291458.</abstract><cop>Berlin/Heidelberg</cop><pub>Springer Berlin Heidelberg</pub><pmid>30377712</pmid><doi>10.1007/s00125-018-4752-6</doi><tpages>11</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0012-186X
ispartof Diabetologia, 2019-01, Vol.62 (1), p.112-122
issn 0012-186X
1432-0428
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6290676
source Springer Link
subjects Adipose tissue
Adipose tissue (brown)
Adipose Tissue, Brown - drug effects
Adipose Tissue, Brown - metabolism
Adult
Arginine
Arginine - therapeutic use
Biopsy
Blood Glucose
Body Mass Index
Body weight
Calorimetry
Computed tomography
Cross-Over Studies
Diabetes
Diabetes mellitus
Diabetes mellitus (non-insulin dependent)
Diabetes Mellitus, Type 2 - drug therapy
Diabetes Mellitus, Type 2 - metabolism
Double-Blind Method
Electron transport
Energy metabolism
Energy Metabolism - drug effects
Ethnicity
Fasting
Glucose
Glucose metabolism
Glucose tolerance
Human Physiology
Humans
Insulin
Internal Medicine
Laboratory testing
Male
Medicine
Medicine & Public Health
Mens health
Metabolic Diseases
Metabolic rate
Metabolism
Middle Aged
Minority & ethnic groups
Mitochondria
Muscle, Skeletal - drug effects
Muscle, Skeletal - metabolism
Musculoskeletal system
Nitric oxide
Overweight
Oxidation
Positron emission tomography
Prediabetic State
Respiration
Skeletal muscle
Supplements
Thermogenesis - drug effects
title Effect of l-arginine on energy metabolism, skeletal muscle and brown adipose tissue in South Asian and Europid prediabetic men: a randomised double-blinded crossover study
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-09-21T17%3A39%3A30IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Effect%20of%20l-arginine%20on%20energy%20metabolism,%20skeletal%20muscle%20and%20brown%20adipose%20tissue%20in%20South%20Asian%20and%20Europid%20prediabetic%20men:%20a%20randomised%20double-blinded%20crossover%20study&rft.jtitle=Diabetologia&rft.au=Boon,%20Mari%C3%ABtte%20R.&rft.date=2019-01-01&rft.volume=62&rft.issue=1&rft.spage=112&rft.epage=122&rft.pages=112-122&rft.issn=0012-186X&rft.eissn=1432-0428&rft_id=info:doi/10.1007/s00125-018-4752-6&rft_dat=%3Cproquest_pubme%3E2127090492%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c470t-857923622ae8d8d8f532cf7e62fb75ec6ee6054ddff868eb74c55302b6a10f863%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2127090492&rft_id=info:pmid/30377712&rfr_iscdi=true